rs7514229 — TNFSF4 TNFSF4 OX40 ligand variant

Intronic variant in TNFSF4 that tags an upstream regulatory haplotype associated with altered OX40 ligand expression, influencing T cell co-stimulation and susceptibility to autoimmune thyroid disease and viral immune responses

See your personal result for TNFSF4

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

TNFSF4 rs7514229 — OX40 Ligand and the T Cell Co-stimulation Gate

Every adaptive immune response requires a second signal beyond antigen recognition. The OX40–OX40L axis11 OX40–OX40L axis
OX40 (CD134) is a co-stimulatory receptor on activated T cells; its ligand OX40L (CD252) is expressed on antigen-presenting cells and provides the survival and proliferation signal that determines whether a T cell response is sustained or terminated is one of the most important of those second signals — controlling whether activated T cells survive, expand into effector cells, and help B cells mature into antibody-secreting plasma cells. TNFSF4, the gene encoding OX40 ligand (OX40L), sits on chromosome 1q25 and contains a regulatory upstream region that has been consistently implicated in systemic autoimmunity. rs7514229 is an intronic variant within TNFSF4 that tags this regulatory haplotype and has been linked to altered OX40L expression, autoimmune thyroid disease, and viral immune control.

The Mechanism

rs7514229 maps to an intronic position within TNFSF4 on chromosome 1 (GRCh38 chr1:173,185,165). TNFSF4 itself is transcribed from the minus strand, but dbSNP reports alleles on the plus strand — the reference allele is G, the alternate allele is T. As an intronic variant, rs7514229 does not change the OX40L amino acid sequence; instead, it serves as a tag for a broader upstream regulatory haplotype22 a broader upstream regulatory haplotype
Cunninghame Graham et al. Nature Genetics 2008 (PMID 18059267) identified four SNPs showing significant overtransmission in SLE families and demonstrated that susceptibility alleles were associated with a 6.7-fold increase in TNFSF4 transcript expression (P=0.008) in the TNFSF4 promoter region.

The functional consequence is altered OX40L surface expression. Higher OX40L on antigen-presenting cells strengthens OX40 signaling on T cells, promoting T cell survival beyond the normal timeframe, amplifying Th2-skewed responses, and providing excessive help to B cells in germinal centers — driving sustained antibody production, including autoantibodies. Bioinformatic analysis of the intronic rs7514229-T allele suggests it may also disrupt miRNA binding sites33 miRNA binding sites
A regulatory mechanism by which microRNA molecules bind to complementary sequences in mRNA, typically in untranslated regions, to suppress gene expression, potentially further modulating TNFSF4 transcript stability or translation.

The Evidence

The foundational association between TNFSF4 and autoimmunity was established in a landmark 2008 Nature Genetics paper44 landmark 2008 Nature Genetics paper
Cunninghame Graham et al. — two independent European SLE cohorts (UK WTCCC + US NIH), 36 SNPs across TNFSF4, four showing significant overtransmission; risk haplotype carriers showed 6.7-fold elevated TNFSF4 RNA expression in cells with susceptibility alleles that genotyped rs7514229 among 36 TNFSF4 variants and linked the upstream haplotype to SLE through elevated OX40L expression. This was subsequently replicated55 replicated
Delgado-Vega et al. Genes & Immunity 2009 (PMID 19092840) — 1,312 cases, 1,801 controls; four European and Argentine cohorts; pooled OR=1.38–1.39 for the tagging haplotype across multiple European and Latin American populations.

Directly at rs7514229, a 2016 Chinese case-control study66 2016 Chinese case-control study
Song et al. Int J Mol Sci 2016 (PMID 27556446) — 1,048 AITD patients and 909 healthy controls, Han Chinese; four tagging SNPs in the TNFSF4 region found that the GG genotype at rs7514229 (homozygous reference, no T allele) was significantly associated with early-onset autoimmune thyroid disease (AITD) in patients aged ≤18 years. This population-specific finding, where G is the major allele in East Asians (~89%), points to a complex regulatory relationship in which the T/G haplotype context — rather than a simple additive dose — determines TNFSF4 expression thresholds relevant to thyroid autoimmunity during adolescent immune development.

A 2021 Chinese HCV study77 2021 Chinese HCV study
Fu et al. Frontiers in Genetics 2021 (PMID 33841497) — 3,690 participants including 2,309 uninfected controls, 597 spontaneous clearers, and 784 persistent HCV infection patients; false discovery rate corrected found rs7514229-T associated with increased HCV persistence risk. Individuals carrying multiple risk alleles (rs7514229-T plus rs3181366-T) showed a dose-dependent increase in infection susceptibility (P_trend<0.001), with bioinformatic evidence that T disrupts a miRNA binding site affecting TNFSF4 transcript regulation.

Practical Implications

OX40L/TNFSF4 operates at the interface of T cell survival and B cell help — two processes central to the autoimmune cycle. Carriers of rs7514229-T may have altered OX40L expression that shifts this balance toward sustained immune activation. The actionable response focuses on early recognition of autoimmune thyroid disease, one of the most common OX40L-linked conditions, and awareness of HCV risk in relevant contexts.

Autoimmune thyroid disease presents in two main forms: Graves' disease88 Graves' disease
Autoimmune hyperthyroidism where TSH receptor autoantibodies stimulate thyroid hormone overproduction; characterized by weight loss, heat intolerance, palpitations, and sometimes exophthalmos (bulging eyes) and Hashimoto's thyroiditis99 Hashimoto's thyroiditis
Autoimmune hypothyroidism where lymphocytic infiltration destroys thyroid tissue; characterized by fatigue, cold intolerance, weight gain, and goiter. Both are diagnosable with standard thyroid function tests (TSH, free T4, free T3) and thyroid autoantibodies (anti-TPO, anti-thyroglobulin, TSH receptor antibodies).

Interactions

TNFSF4 does not operate in isolation from the broader autoimmune susceptibility landscape. A gene-gene interaction study in Chinese SLE1010 gene-gene interaction study in Chinese SLE
Wang et al. 2011 (PMID 21905002) — multiplicative interaction model in 806 cases and 806 controls found a significant interaction between BLK rs2736340 and TNFSF4 in SLE susceptibility (P=6.57×10⁻⁴). BLK encodes a B-cell tyrosine kinase critical for self-tolerance; reduced BLK expression (from the rs2736340 risk allele) combined with elevated OX40L co-stimulation from the TNFSF4 risk haplotype creates a dual defect — impaired B cell tolerance plus amplified T cell help for autoreactive B cells. The nearby TNFSF4 variants rs2205960 and rs1234317 (from the SLE-associated haplotype) and rs3850641 (associated with Hashimoto's hypothyroidism) represent functionally overlapping signals within the same regulatory region that may compound with rs7514229 on the same haplotype.

Genotype Interpretations

What each possible genotype means for this variant.

GG Typical OX40L Signaling Normal

Common homozygous reference genotype — no T allele, typical TNFSF4 background risk

You carry two copies of the G reference allele at rs7514229. This is the most common genotype globally, present in approximately 33% of people. In European populations the G allele frequency is about 67%, making GG the most common European genotype at roughly 45%. You do not carry the T alternate allele that tags the TNFSF4 upstream regulatory haplotype associated with altered OX40L expression in the published literature. Your baseline genetic risk from this specific variant for TNFSF4-driven autoimmune disease is at or below the population average.

GT One T Allele Intermediate

Heterozygous — one copy of the TNFSF4 regulatory risk allele

The T allele at rs7514229 tags a broader TNFSF4 upstream regulatory haplotype. The 2008 Nature Genetics study (PMID 18059267) demonstrated that this haplotype correlates with a 6.7-fold increase in TNFSF4 RNA expression in susceptibility carriers. Elevated OX40L surface expression strengthens co-stimulatory signaling to activated T cells, extending their survival and amplifying B cell help — processes central to the sustained antibody production characteristic of autoimmune disease.

In the AITD-specific study in Chinese populations (PMID 27556446), rs7514229 was one of four tagging SNPs examined for associations with autoimmune thyroid disease. The 2021 HCV study (PMID 33841497) further found rs7514229-T associated with increased HCV infection risk, with bioinformatic evidence suggesting the T allele disrupts a miRNA binding site in the TNFSF4 transcript region, potentially altering OX40L regulation in antiviral immune contexts.

TT Two T Alleles High Risk

Homozygous T allele — elevated TNFSF4 regulatory risk, both copies of T alternate allele

OX40L (encoded by TNFSF4) delivers a survival and proliferation signal to OX40-expressing T cells during antigen presentation. When TNFSF4 expression is elevated through regulatory haplotype effects, T cells receive stronger and more sustained co-stimulation — extending effector T cell lifespan, amplifying Th2 cytokine output, and providing excess "help" to B cells in germinal centers. The result is heightened antibody production capacity, including the production of autoantibodies when self-antigen presentation occurs.

The 2008 Nature Genetics paper (PMID 18059267) established the foundational biology: risk-haplotype carriers showed a 6.7-fold increase in TNFSF4 transcript levels (P=0.008), a magnitude sufficient to meaningfully shift the T cell activation threshold. Under additive genetics, TT homozygotes carry double the per-allele effect of GT heterozygotes. The TNFSF4 locus is one of the most replicated genetic associations for SLE susceptibility (meta-analysis PMID 22850862; replication in multiple European and Latin American cohorts PMID 19092840).

The autoimmune thyroid disease association at rs7514229 specifically was identified in Han Chinese adolescent AITD patients (PMID 27556446), where the GG genotype was associated with early-onset disease — a finding likely reflecting population-specific haplotype structure where different regulatory allele combinations dominate in East Asian versus European ancestries. Across both ancestral contexts, the TNFSF4 regulatory region remains a risk locus for thyroid autoimmunity.

Additionally, the rs7514229-T allele was associated with increased susceptibility to persistent HCV infection (PMID 33841497), suggesting that TNFSF4 regulatory variants affect not only the autoimmune-promoting arm of T cell co-stimulation but also antiviral immunity.